Skip to main content
Pfizer Inc.
Healthcare · Drug Manufacturers - General
Made on Aug 6, 2026
Price at call $25.81
6-month call Bull +7.5%
Target by Feb 2027 $27.75
Great value below $22.50
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +7.5% to $27.75
Predicted High $27.75 at 6 months
Predicted Low $26.05 in 2 weeks

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 6, 2026 1:07 am
Bull PFE trends higher to $27.75 (+7.5% from $25.81) by Feb 2027. other
ThesisPFE trades well below composite fair value with defensive characteristics and consistent earnings beats, but a fallen-angel narrative and weak quality score cap enthusiasm. Expect gradual drift higher toward the mid-to-high 20s as value gravity slowly works, with modest early momentum from the risk-on regime.
Invalidated ifA dividend cut, pipeline setback, or drop below $23 would falsify the slow-grind-higher thesis
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $25.81 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 6, 2026 $25.81 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 20, 2026 $24.77–$26.85 typical range · internal point $26.05 ±4.0% 6/10 Risk-on regime supports modest drift from current levels
What actually happened: closed $28.24 on Aug 19, 2026 = +9.4% vs the call (predicted +0.9%)  ·  direction MISS (called flat, was up)  ·  off by 8.5 pp  ·  accuracy 4/10  ·  typical range ±4.0%: OUTSIDE the band  ·  S&P 0.0% over the same window — beat it
1 month Sep 6, 2026 $24.30–$27.32 typical range · internal point $26.30 ±5.9% 6/10 Low-beta defensive bid continues in absence of catalysts
2 months Oct 6, 2026 $26.65 +3.3% 5/10 Q3 earnings anticipation with 5-of-5 beat streak
3 months Nov 6, 2026 $27.20 +5.4% 5/10 Likely earnings beat reinforces guidance credibility
4 months Dec 6, 2026 $27.45 +6.4% 4/10 Value gravity toward composite fair value continues
5 months Jan 6, 2027 $27.10 +5.0% 4/10 Year-end tax-loss pressure on unloved names
6 months Feb 6, 2027 $27.75 +7.5% 3/10 New-year rotation into defensive value laggards

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $26.97 (+4.5%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$25.81
Composite fair value$32.78
Signal-adjusted fair value$31.09
DCF fair value$24.14
Anchored-PE fair value$22.34
Buy-below (value lens)$22.50
Value net score+6
Value confidence6 / 10
Quality net score+13
Memo confidence6 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 17.3%  3m 20.3%  6m 21.2%  
Daily σ (realism noise)1.3%
Beta vs S&P 500 1m 0.08  3m -0.03  5m 0.14  
Trailing 6-month return-0.6%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 6, 2026 freshest PFE-20260806-000518-6d33
ext-forensic-memo Aug 6, 2026 freshest ext-PFE-20260806-005228-ea07
ext-lens-quality Aug 6, 2026 freshest ext-PFE-20260806-005228-ea07
ext-lens-sentiment Aug 6, 2026 freshest ext-PFE-20260806-005228-ea07
ext-lens-value Aug 6, 2026 freshest ext-PFE-20260806-005228-ea07
scenario-valuation Aug 6, 2026 freshest PFE-20260806-000518-6d33
valuation-synthesis Aug 6, 2026 freshest PFE-20260806-000518-6d33

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 6, 2026 v0.6.0 Bull $25.81 $27.75 +7.5% Feb 2027 viewing
Jun 30, 2026 v0.3.0 Bull $24.39 $25.99 +6.6% Dec 2026 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.